Skip to main content

Table 2 Clinical information of HIV-1 seropositive donors on combination ART (longitudinal study)

From: Transcriptome analysis of monocyte-HIV interactions

  

CD4T count (cells/mm3)

VL (log copies/ml)

Patient ID

Experiment

BL

M3

M6

M9

BL

M3

M6

M9

HA 01

MAS

239

373

407

502

4.61

2.37

< 1.70

< 1.70

HA 02

MAS

153

222

353

263

5.36

1.75

1.85

< 1.70

HA 03

MAS

193

441

446

437

5.36

2.84

1.72

2.05

HA 04

MAS

273

608

577

761

4.58

< 1.70

< 1.70

< 1.70

HA 05

MAS

548

592

956

778

4.88

2.12

< 1.70

< 1.70

HA 06

MAS

239

317

348

591

5.01

< 2.60

< 1.70

< 1.70

HA 07

MAS

165

209

282

222

5.13

< 2.60

< 2.60

< 1.70

HA 08

MAS

146

241

264

315

4.48

< 1.70

< 1.70

< 1.70

HA 09

MAS

205

ND

400

318

5.45

ND

< 1.70

< 1.70

HA 10

MAS

269

327

451

372

5.26

< 1.70

< 1.70

< 1.70

HA 11

MAS

324

707

561

590

5.68

3.26

< 2.60

< 2.60

HA 12

MAS

202

245

254

242

5.16

< 1.70

< 1.70

< 1.70

HA 13

MAS

261

ND

425

432

5.77

ND

< 1.70

< 1.70

HA 14

MAS

318

257

270

338

5.14

< 1.70

< 1.70

< 1.70

HA 15

MAS

258

524

462

300

4.57

2.35

< 1.70

< 1.70

HA 16

MAS

232

356

358

318

5.57

< 2.60

3.85

< 1.70

  1. MAS: custom Macrophage Activation State array platform; CL: commercial CodeLink HWG bioarray platform; CD4T: CD4+ T lymphocyte; VL: viral load; BL: baseline; M3/6/9: sample taken resp. 3, 6 and 9 months after therapy initiation; ND: not done.